SCHEMBL19675437

SCHEMBL19675437

CC(C)C(=O)/C(C=N)=C1\C=CC=CN1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14540235 0.74 NPC1 (0.31) NPC1RAB9AHSD17B10
SCHEMBL14037435 0.74 NPC1 (0.34) NPC1RAB9AHSD17B10
SCHEMBL19676646 0.73
SCHEMBL27249982 0.70 NPC1 (0.30) NPC1RAB9AHSD17B10
SCHEMBL20229777 0.67
SCHEMBL19675724 0.66 ALDH1A1 (0.33)
SCHEMBL8017408 0.55
SCHEMBL19675335 0.54
SCHEMBL14373993 0.54
SCHEMBL19675149 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3252050-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed
EP-3252049-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed